Developer docs
API playgroundTry for free, no card

Search company profiles

Ashfield Engage

Full company profile

uuid000pkxr

Namestring
Ashfield Engage
Legal namestring
Ashfield Healthcare Ltd
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Ashfield Engage, now operating under the parent brand Inizio Engage (formerly UDG Healthcare), is a global healthcare engagement and commercialization partner serving pharmaceutical, biotechnology, and broader life sciences organizations. The company delivers a multi-service platform organized into six core practice areas: Decision Optimization (data, analytics, market access, and treatment experience design), XD/Experience Design (creative, events, learning, digital/immersive, patient and customer experience), Patient Solutions (hub services, access, adherence support across the US, Europe, and Canada), Medical Affairs (medical information and Medical Science Liaisons), Commercial Solutions (field sales deployment, HCP segmentation, remote engagement, key account management, field reimbursement, omnichannel consulting), and Recruitment Solutions (executive and talent search). Its core end customers are large pharma and biotech manufacturers needing outsourced commercial, medical, and patient engagement capabilities across global markets.

The underlying technology stack is anchored by two proprietary assets: the Nuvera platform (treatment experience design and independent industry benchmark reporting) and Propensity4 (data and integrated insights platform for healthcare and patient engagement analytics), the latter acquired in May 2022. The business model is enterprise B2B professional services, with revenue generated through long-term strategic partnerships, project-based engagements, and dedicated embedded teams such as contract sales forces, MSLs, field reimbursement managers, and patient hub operators. Pricing is not publicly disclosed and is customized per engagement. GTM is direct enterprise sales to life sciences manufacturers, supplemented by content-led demand generation through thought leadership, reports (e.g., The Future of Field Excellence), industry events, and partnership referrals. Ashfield Engage is a wholly-owned subsidiary of Inizio Engage, itself formerly UDG Healthcare, providing shared infrastructure across more than ten specialist sub-brands (Nazaré, Forty1, Emota, Nuvera, Propensity4, Axiom, Cormis, Logicearth, WRG, Ashfield Excellence Academy, Ashfield Event Experiences).

Short descriptiontext

Ashfield Engage is a global healthcare engagement and commercialization partner that delivers outsourced commercial, medical affairs, patient solutions, and data analytics services to pharmaceutical and biotech clients across 20+ countries using a 6,000+ person workforce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersFort Washington, United States
HQ citystring
Fort Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare engagement services, pharmaceutical commercialization, patient support programs, medical affairs solutions, HCP engagement solutions
Industry2 codes
1Strategic Partnerships, Alliances & JVs Advisory
CodeBPAHADAIPrimaryYes
2Agent of Record (AOR) / Contractor Engagement Services
CodeBPACAGABPrimaryNo
NAICS code3 codes
  • Management Consulting Services54161
  • Marketing Consulting Services541613
  • Human Resources Consulting Services541612
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Engagement and Commercialization Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Engagement Services
TypeProfessional Services
Description

Professional services providing strategic engagement solutions to pharmaceutical and biotech companies, including patient solutions, medical affairs support, commercial solutions, and recruitment services. Revenue generated through long-term strategic partnerships and project-based engagements with life sciences organizations.

inizioengage.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Propensity4
Description

Data and Integrated Insights specialist brand providing healthcare analytics solutions.

inizioengage.com
+3 more records
Core offering1 text field

Ashfield Engage is a global healthcare engagement and commercialization partner that delivers patient solutions, medical affairs support, commercial solutions, recruitment services, decision-optimization strategy, and experience design services to pharmaceutical, biotechnology and broader life sciences organizations. Its services are powered by proprietary platforms including Propensity4 (data and integrated insights) and Nuvera (treatment experience design and independent industry benchmark reporting).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ashfield Engage (now operating as Inizio Engage) is a global healthcare engagement and commercialization partner offering a multi-service platform architecture. The company delivers data-driven strategy, creative solutions, and advanced analytics to life sciences organizations through six core service areas: Decision Optimization (including Data and Integrated Insights Powered by Propensity4, Independent Industry Benchmark Reporting and Treatment Experience Design Powered by Nuvera, and Market Access Strategy), XD (Experience Design covering Learning & Capabilities, Meetings/Events & Exhibitions, Employee Experience, Film, Digital & Immersive, and PX+CX), Patient Solutions (US, Europe, Canada), Medical Affairs (Medical Information and MSLs), Commercial Solutions (Sales & Service Representatives, HCP Segmentation & Targeting, Remote HCP Engagement, Omnichannel Consulting and Analytics, Commercial Insights Generation, KAM, FRMs), and Recruitment Solutions (Executive Search and Talent Search). The portfolio also includes specialist brands including Propensity4 (acquired healthcare analytics company), Nuvera, Nazaré, Forty1, Emota, Ashfield Excellence Academy, Ashfield Event Experiences, Axiom, Cormis, Logicearth, and WRG. The company employs 6,000+ experts across 20+ countries with operations focused on improving patient engagement, HCP engagement, and treatment outcomes.

Product and service1 record
1Decision Optimization
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-10
Description

Ashfield Engage acquired Propensity4, a healthcare insights and analytics company, following a period of partnership and prior investment. The acquisition enhances Ashfield's data-driven strategy and client services, enabling better utilization of analytical platforms for improved patient outcomes and customer engagement worldwide.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Ashfield Engage acquired Medaxis as part of industry consolidation in the patient engagement solutions market. The acquisition contributed to the company's expanded global healthcare engagement capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ashfield Engage is part of UDG Healthcare, a global healthcare services company. This parent-subsidiary relationship provides integration with a broader healthcare services ecosystem and enables comprehensive engagement solutions across the healthcare value chain.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Syneos Health is a direct competitor offering contract sales, clinical and commercial services to pharma/biotech, with comparable field deployment, patient solutions, and medical affairs offerings targeting the same customer base as Ashfield Engage.

TypeBroad incumbent
Description

IQVIA is the largest healthcare-focused incumbent combining data, analytics, clinical research and commercial services; its R&DS (Real-World & Data Sciences) and commercial solutions directly overlap Ashfield Engage's Decision Optimization, Patient Solutions, and Commercial offerings with broader portfolio scale.

TypeDirect peer
Description

EVERSANA is a closely comparable commercial-services partner providing patient services, market access, field deployment, medical affairs, and analytics to life sciences clients across US and global markets, competing head-to-head on most of Ashfield Engage's core service areas.

TypeDirect peer
Description

Fishawack Health is a global commercialization and medical communications partner that offers medical affairs, patient engagement and creative services to pharma clients, mirroring Ashfield Engage's XD, Medical Affairs, and Patient Solutions offerings.

TypeDirect peer
Description

Avalere Health (formerly Avalere/Innovative Health Science) provides market access, patient services, HEOR and commercial consulting to pharma and biotech, overlapping strongly with Ashfield Engage's Decision Optimization and Patient Solutions lines.

TypeDirect peer
Description

OPEN Health is a global commercialization and medical communications platform serving pharma with patient engagement, medical affairs, market access and experience design services, closely comparable to Ashfield Engage's multi-service portfolio.

TypeDirect peer
Description

Trinity Life Sciences provides strategy, insights, and commercial consulting to pharma/biotech — directly comparable to Ashfield Engage's Decision Optimization, Treatment Experience Design, and Commercial Insights capabilities.

TypeDirect peer
Description

ZS Associates is a global consulting firm specializing in sales, marketing and analytics for pharma, directly comparable to Ashfield Engage's HCP segmentation, key account management, omnichannel consulting, and sales rep deployment offerings.

TypeEmerging player
Description

Lumanity is a commercial and evidence-based solutions partner built from the merger of pretty much Ashfield-adjacent firms; it offers consulting, medical affairs, and patient engagement to pharma, partially overlapping Ashfield Engage's Decision Optimization and Patient Solutions offerings.

TypeBroad incumbent
Description

Parexel is a large CRO and biopharmaceutical services firm whose commercialization and patient services lines overlap with Ashfield Engage's commercial and medical affairs offerings for life sciences clients globally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ashfield Engage

Healthcare Engagement and Commercialization Servicesashfieldengage.com

Ashfield Engage is a global healthcare engagement and commercialization partner that delivers outsourced commercial, medical affairs, patient solutions, and data analytics services to pharmaceutical and biotech clients across 20+ countries using a 6,000+ person workforce.

What Ashfield Engage does

Ashfield Engage, now operating under the parent brand Inizio Engage (formerly UDG Healthcare), is a global healthcare engagement and commercialization partner serving pharmaceutical, biotechnology, and broader life sciences organizations. The company delivers a multi-service platform organized into six core practice areas: Decision Optimization (data, analytics, market access, and treatment experience design), XD/Experience Design (creative, events, learning, digital/immersive, patient and customer experience), Patient Solutions (hub services, access, adherence support across the US, Europe, and Canada), Medical Affairs (medical information and Medical Science Liaisons), Commercial Solutions (field sales deployment, HCP segmentation, remote engagement, key account management, field reimbursement, omnichannel consulting), and Recruitment Solutions (executive and talent search). Its core end customers are large pharma and biotech manufacturers needing outsourced commercial, medical, and patient engagement capabilities across global markets.

The underlying technology stack is anchored by two proprietary assets: the Nuvera platform (treatment experience design and independent industry benchmark reporting) and Propensity4 (data and integrated insights platform for healthcare and patient engagement analytics), the latter acquired in May 2022. The business model is enterprise B2B professional services, with revenue generated through long-term strategic partnerships, project-based engagements, and dedicated embedded teams such as contract sales forces, MSLs, field reimbursement managers, and patient hub operators. Pricing is not publicly disclosed and is customized per engagement. GTM is direct enterprise sales to life sciences manufacturers, supplemented by content-led demand generation through thought leadership, reports (e.g., The Future of Field Excellence), industry events, and partnership referrals. Ashfield Engage is a wholly-owned subsidiary of Inizio Engage, itself formerly UDG Healthcare, providing shared infrastructure across more than ten specialist sub-brands (Nazaré, Forty1, Emota, Nuvera, Propensity4, Axiom, Cormis, Logicearth, WRG, Ashfield Excellence Academy, Ashfield Event Experiences).

Ashfield Engage firmographics

Firmographics
Name
Ashfield Engage
Legal name
Ashfield Healthcare Ltd
Website
https://ashfieldengage.com
Company type
Private
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Ashfield Engage is a global healthcare engagement and commercialization partner that delivers outsourced commercial, medical affairs, patient solutions, and data analytics services to pharmaceutical and biotech clients across 20+ countries using a 6,000+ person workforce.
Ownership category
akta.pro rank

Ashfield Engage industry classification

Industry
Product category
Healthcare Engagement and Commercialization Services
NAICS
Management Consulting Services (54161), Marketing Consulting Services (541613), Human Resources Consulting Services (541612)
SIC
Services-Management Consulting Services (8742)
akta.pro primary industry
Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI)
akta.pro secondary industry
Agent of Record (AOR) / Contractor Engagement Services (BPACAGAB)

Keywords

  • Healthcare engagement services
  • Pharmaceutical commercialization
  • Patient support programs
  • Medical affairs solutions
  • HCP engagement solutions

Where Ashfield Engage is headquartered

Location

Headquarters

HQ city
Fort Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Ashfield Engage business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Healthcare Engagement Services: Professional services providing strategic engagement solutions to pharmaceutical and biotech companies, including patient solutions, medical affairs support, commercial solutions, and recruitment services. Revenue generated through long-term strategic partnerships and project-based engagements with life sciences organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Ashfield Engage product offering

Product offering

Core offering

Ashfield Engage is a global healthcare engagement and commercialization partner that delivers patient solutions, medical affairs support, commercial solutions, recruitment services, decision-optimization strategy, and experience design services to pharmaceutical, biotechnology and broader life sciences organizations. Its services are powered by proprietary platforms including Propensity4 (data and integrated insights) and Nuvera (treatment experience design and independent industry benchmark reporting).

Product overview

Ashfield Engage (now operating as Inizio Engage) is a global healthcare engagement and commercialization partner offering a multi-service platform architecture. The company delivers data-driven strategy, creative solutions, and advanced analytics to life sciences organizations through six core service areas: Decision Optimization (including Data and Integrated Insights Powered by Propensity4, Independent Industry Benchmark Reporting and Treatment Experience Design Powered by Nuvera, and Market Access Strategy), XD (Experience Design covering Learning & Capabilities, Meetings/Events & Exhibitions, Employee Experience, Film, Digital & Immersive, and PX+CX), Patient Solutions (US, Europe, Canada), Medical Affairs (Medical Information and MSLs), Commercial Solutions (Sales & Service Representatives, HCP Segmentation & Targeting, Remote HCP Engagement, Omnichannel Consulting and Analytics, Commercial Insights Generation, KAM, FRMs), and Recruitment Solutions (Executive Search and Talent Search). The portfolio also includes specialist brands including Propensity4 (acquired healthcare analytics company), Nuvera, Nazaré, Forty1, Emota, Ashfield Excellence Academy, Ashfield Event Experiences, Axiom, Cormis, Logicearth, and WRG. The company employs 6,000+ experts across 20+ countries with operations focused on improving patient engagement, HCP engagement, and treatment outcomes.

Differentiator

Problem solved

Functional benefit

Brands

  • Propensity4: Data and Integrated Insights specialist brand providing healthcare analytics solutions.
  • Nuvera
  • Ashfield Excellence Academy
  • Ashfield Event Experiences

Products and services

  • Decision Optimization

Companies that use Ashfield Engage

Customer profile

Segments3 records

Ideal customer profiles3 records

Ashfield Engage technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Ashfield Engage partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Propensity4coreStrategic or Co-development Partner · 10 May 2022Ashfield Engage acquired Propensity4, a healthcare insights and analytics company, following a period of partnership and prior investment. The acquisition enhances Ashfield's data-driven strategy and client services, enabling better utilization of analytical platforms for improved patient outcomes and customer engagement worldwide.
  • MedaxiscoreStrategic or Co-development Partner · 1 January 2022Ashfield Engage acquired Medaxis as part of industry consolidation in the patient engagement solutions market. The acquisition contributed to the company's expanded global healthcare engagement capabilities.
  • UDG HealthcarecoreStrategic or Co-development PartnerAshfield Engage is part of UDG Healthcare, a global healthcare services company. This parent-subsidiary relationship provides integration with a broader healthcare services ecosystem and enables comprehensive engagement solutions across the healthcare value chain.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Ashfield Engage competitors and assessment

Company assessment

Direct peers

  • Syneos Health: Syneos Health is a direct competitor offering contract sales, clinical and commercial services to pharma/biotech, with comparable field deployment, patient solutions, and medical affairs offerings targeting the same customer base as Ashfield Engage.
  • EVERSANA: EVERSANA is a closely comparable commercial-services partner providing patient services, market access, field deployment, medical affairs, and analytics to life sciences clients across US and global markets, competing head-to-head on most of Ashfield Engage's core service areas.
  • Fishawack Health: Fishawack Health is a global commercialization and medical communications partner that offers medical affairs, patient engagement and creative services to pharma clients, mirroring Ashfield Engage's XD, Medical Affairs, and Patient Solutions offerings.
  • Avalere Health: Avalere Health (formerly Avalere/Innovative Health Science) provides market access, patient services, HEOR and commercial consulting to pharma and biotech, overlapping strongly with Ashfield Engage's Decision Optimization and Patient Solutions lines.
  • OPEN Health Group: OPEN Health is a global commercialization and medical communications platform serving pharma with patient engagement, medical affairs, market access and experience design services, closely comparable to Ashfield Engage's multi-service portfolio.
  • Trinity Life Sciences: Trinity Life Sciences provides strategy, insights, and commercial consulting to pharma/biotech — directly comparable to Ashfield Engage's Decision Optimization, Treatment Experience Design, and Commercial Insights capabilities.
  • ZS Associates: ZS Associates is a global consulting firm specializing in sales, marketing and analytics for pharma, directly comparable to Ashfield Engage's HCP segmentation, key account management, omnichannel consulting, and sales rep deployment offerings.

Broad incumbents

  • IQVIA: IQVIA is the largest healthcare-focused incumbent combining data, analytics, clinical research and commercial services; its R&DS (Real-World & Data Sciences) and commercial solutions directly overlap Ashfield Engage's Decision Optimization, Patient Solutions, and Commercial offerings with broader portfolio scale.
  • Parexel International: Parexel is a large CRO and biopharmaceutical services firm whose commercialization and patient services lines overlap with Ashfield Engage's commercial and medical affairs offerings for life sciences clients globally.

Emerging players

  • Lumanity: Lumanity is a commercial and evidence-based solutions partner built from the merger of pretty much Ashfield-adjacent firms; it offers consulting, medical affairs, and patient engagement to pharma, partially overlapping Ashfield Engage's Decision Optimization and Patient Solutions offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Ashfield Engage financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ashfield Engage leadership team

Management profile

Number of profiles

Ashfield Engage subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Ashfield Engage funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ashfield Engage M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ashfield Engage

What does Ashfield Engage do?

Ashfield Engage is a global healthcare engagement and commercialization partner that delivers patient solutions, medical affairs support, commercial solutions, recruitment services, decision-optimization strategy, and experience design services to pharmaceutical, biotechnology and broader life sciences organizations. Its services are powered by proprietary platforms including Propensity4 (data and integrated insights) and Nuvera (treatment experience design and independent industry benchmark reporting).

Is Ashfield Engage a public or private company?

Ashfield Engage is a private company. It is classified as corporate owned and is currently operating.

When was Ashfield Engage founded?

Ashfield Engage was founded in -1. It employs 1,001 to 5,000 people.

Where is Ashfield Engage based?

Ashfield Engage is headquartered in Fort Washington, United States, in the North America region.

How does Ashfield Engage make money?

One revenue line is on record: healthcare Engagement Services.

Who are Ashfield Engage's main competitors?

Direct peers on record are Syneos Health, EVERSANA, Fishawack Health, Avalere Health, OPEN Health Group, Trinity Life Sciences and ZS Associates. Broad incumbents are IQVIA and Parexel International. Lumanity is listed as an emerging player.

Does Ashfield Engage have an API?

No public API is recorded for Ashfield Engage.

What industry is Ashfield Engage in?

Ashfield Engage's product category is Healthcare Engagement and Commercialization Services. Its primary akta.pro industry code is BPAHADAI, Strategic Partnerships, Alliances & JVs Advisory, with a secondary code of BPACAGAB, Agent of Record (AOR) / Contractor Engagement Services. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comUnited States Patient Engagement Solutions Market 2024-2031: Expanding at a 19.1% CAGRThe United States Patient Engagement Solutions Market is projected to grow at a compound annual growth rate of 19.1% from 2024 to 2031, according to a market research report published by DataM Intelligence. These solutions, which include software, services, and hardware enabling patients to manage healthcare information and interact with medical teams, have seen accelerated adoption driven by post-COVID-19 telehealth expansion and policies such as the CARES Act. Industry consolidation is ongoing, including Ashfield Engage's acquisition of Medaxis in January 2022, with major players like Cerner and McKesson bolstering their digital portfolios.InizioengageReady for launch? Key considerations when launching a product in today’s healthcare environmentA promotional article from Ashfield Engage outlines six factors pharma companies should address when launching products, including identifying patient moments, data-driven decision-making, cross-functional coordination, omnichannel engagement, patient support and rapid launch readiness. It cites acquisitions of PROPENSITY4 and Nuvera, and a client program that enrolled over 35,000 patients with 97% satisfaction.GlobeNewswirePatient Engagement Solutions Market to Reach $41.6 Billion, Growing Technological Innovations in Healthcare to Drive Demand | Fact.MRThe patient engagement solutions market is projected to grow from over $29 billion in 2022 to $66.4 billion by 2032, an 8.6% CAGR. Growth is driven by telemedicine, digital health, and self-hosted platforms, with e-health apps reaching $1.84 billion by 2023. Ashfield Engage's acquisition of Medaxis and a UST-Well-Beat partnership are key strategic moves.PR NewswirePatient Engagement Solutions to Witness US$ 66.4 Billion Market Opportunity, Registering 8.6% CAGR by 2032Fact.MR's market research report projects the global patient engagement solutions market to grow from US$ 29 billion in 2022 to US$ 66.4 billion by 2032, representing a 2.2x increase over the decade, driven by AI adoption, wearable technologies, and favorable government reimbursement policies. Key restraints include high system maintenance costs and a shortage of skilled IT professionals in healthcare. Notable transactions include Ashfield Engage's acquisition of Medaxis in January 2022 and UST's partnership with Israeli behavioral AI company Well-Beat in March 2022.World Pharma TodayAshfield Engage acquires smart data organization PROPENSITY4Ashfield Engage, a subsidiary of UDG Healthcare, has fully acquired smart data organization PROPENSITY4 following years of partnership and an initial investment in 2021. The acquisition aims to enhance Ashfield's analytical capabilities to improve omnichannel outreach and patient engagement strategies for pharmaceutical clients globally.PharmiWeb.comAshfield Engage acquires ‘smart data’ organization PROPENSITY4Ashfield Engage, a division of UDG Healthcare, has acquired PROPENSITY4, a healthcare insights and analytics firm, following a prior investment in 2021 and years of partnership. The acquisition aims to enhance Ashfield Engage's analytical capabilities to improve omnichannel outreach and patient engagement strategies for pharmaceutical clients. This move integrates PROPENSITY4’s proprietary platforms into Ashfield's existing services to drive better return on investment and patient outcomes.PR NewswireSynairgen announces global strategic partnership with Ashfield EngageSynairgen plc announced a global strategic partnership with Ashfield Engage to build commercialization infrastructure for its investigational COVID-19 treatment SNG001 (inhaled interferon-beta), initially targeting the US market pending trial completion and regulatory approvals. Synairgen has completed enrollment of 610 patients in its Phase 3 SPRINTER trial and expects top-line data early 2022, while SNG001 has also advanced to Phase 3 in the NIH's ACTIV-2 trial and holds FDA Fast Track designation. The partnership will involve recruiting medical affairs, patient services, commercial and market access teams, with no financial terms disclosed.PR NewswireAshfield and Patient Connect Form Alliance to Provide Holistic Patient ServicesAshfield Commercial and Medical Services, part of UDG Healthcare plc, has formed a strategic alliance with Patient Connect to improve patient adherence and outcomes by providing pharmaceutical clients with holistic, patient-centric services. The partnership combines Ashfield's field and call centre sales teams, nurse educators, and clinical services with Patient Connect's pharmacy network spanning 10 European countries, the USA, and Australia, reaching nearly 450 million patients. Both companies expressed optimism that the combined expertise will benefit pharmaceutical companies and patients through improved medication management and measurable health outcomes.